Combined olanzapine plus fluoxetine modestly improves symptoms of acute bipolar I depression compared to lamotrigine

被引：0
|
作者：
Brown, E. B. [1 ]
McElroy, S. L. [1 ]
Keck, P. E. [1 ]
机构：
[1] Lilly Corp Ctr, Eli Lilly & Co, Drop Code 4133, Indianapolis, IN 46285 USA
来源：
EVIDENCE-BASED MENTAL HEALTH | 2007年 / 10卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 39 条
  • [31] Genetic association study of serum prolactin increase in olanzapine/fluoxetine combination-treated patients with bipolar I depression
    Houston, John P.
    Iturria, Stephen
    Sutton, Virginia K.
    Farmen, Mark
    Adams, David H.
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 206S - 206S
  • [32] Comparison of Pharmacogenomic Associations with Clinical Change in Olanzapine Fluoxetine Combination Treatment of Patients with Treatment Resistant Depression vs. Bipolar I Depression
    Houston, John P.
    Perlis, Roy
    Dharia, Sweta
    Jacobson, Jennie
    Fijal, Bonnie
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 128S - 128S
  • [33] Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression?
    Möller, HJ
    Bottlender, R
    Grunze, H
    Strauss, A
    Wittmann, J
    JOURNAL OF AFFECTIVE DISORDERS, 2001, 67 (1-3) : 141 - 146
  • [34] Olanzapine/Fluoxetine Combination in Children and Adolescents With Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
    Detke, Holland C.
    DelBello, Melissa P.
    Landry, John
    Usher, Roland W.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2015, 54 (03): : 217 - 224
  • [35] 8-month maintenance treatment of bipolar depression (BD) with lamotrigine (LAM) or divalproex (DIV) plus LAM: Acute phase safety and efficacy of combined LAM and DIV treatment of BD
    Singh, Vivek
    Bowden, Charles L.
    Bernardo, Carmina G.
    Thompson, Peter M.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 191S - 191S
  • [36] Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial
    Bobo, William V.
    Epstein, Richard A.
    Shelton, Richard C.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (01) : 30 - 36
  • [37] Bipolar II compared with bipolar I disorder: baseline characteristics and treatment response to quetiapine in a pooled analysis of five placebo-controlled clinical trials of acute bipolar depression
    Datto, Catherine
    Pottorf, William J.
    Feeley, Louisa
    LaPorte, Scott
    Liss, Charlie
    ANNALS OF GENERAL PSYCHIATRY, 2016, 15
  • [38] Bipolar II compared with bipolar I disorder: baseline characteristics and treatment response to quetiapine in a pooled analysis of five placebo-controlled clinical trials of acute bipolar depression
    Catherine Datto
    William J. Pottorf
    Louisa Feeley
    Scott LaPorte
    Charlie Liss
    Annals of General Psychiatry, 15
  • [39] Adjunctive Armodafinil 150 mg/d in Combination with Lamotrigine, Olanzapine, or Quetiapine Maintenance Therapy for Bipolar I Depression: A Pooled Sub-group Analysis of Efficacy from Phase 3 Studies
    Ketter, Terence
    Amchin, Jess
    Yang, Ronghua
    Frye, Mark A.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S383 - S384
1234